These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3109661)

  • 1. Insulin bolus given by sprinkler needle: effect on absorption and glycaemic response to a meal.
    Edsberg B; Herly D; Hildebrandt P; Kühl C
    Br Med J (Clin Res Ed); 1987 May; 294(6584):1373-6. PubMed ID: 3109661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.
    Kang S; Owens DR; Vora JP; Brange J
    Lancet; 1990 Feb; 335(8685):303-6. PubMed ID: 1967767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional and sprinkler needle injection of magnesium insulin.
    Colagiuri S; Bryson J; Keating S; Tan L; King J; Eigenmann C; Jørgensen KH
    Diabet Med; 1992; 9(7):616-21. PubMed ID: 1511567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthetic human insulin improves postprandial glucose excursions in type I diabetics.
    Gulan M; Gottesman IS; Zinman B
    Ann Intern Med; 1987 Oct; 107(4):506-9. PubMed ID: 3307584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.
    Klauser R; Schernthaner G; Prager R
    Diabetes Res Clin Pract; 1988 Sep; 5(3):185-90. PubMed ID: 3065016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S; Vaag A; Langkjaer L; Hougaard P; Markussen J
    BMJ; 1989 Aug; 299(6696):415-9. PubMed ID: 2506998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
    BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P; Sestoft L; Nielsen SL
    Diabetes Care; 1983; 6(5):459-62. PubMed ID: 6400706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between monocomponent human insulin U-40 and U-100 in CSII treatment of type 1 diabetics.
    Capani F; Carta Q; Vannini P; Ciaverella A; Consoli A; Fiocchi F; Monge L; Vitacolonna E; Sensi S
    Diabetes Res; 1986 Jul; 3(6):317-20. PubMed ID: 3530595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of site and timing of the morning insulin injection in type 1 diabetes.
    Witt MF; White NH; Santiago JV
    J Pediatr; 1983 Oct; 103(4):528-33. PubMed ID: 6352884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
    Vaag A; Pedersen KD; Lauritzen M; Hildebrandt P; Beck-Nielsen H
    Diabet Med; 1990 May; 7(4):335-42. PubMed ID: 2140087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections.
    Hanas SR; Carlsson S; Frid A; Ludvigsson J
    Diabetes Care; 1997 Apr; 20(4):487-90. PubMed ID: 9096966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempts to accelerate glucagon absorption: effects of adding a vasodilator and of injection using a 'sprinkler' needle.
    Simmons KL; Williams G
    Eur J Clin Invest; 1992 Jun; 22(6):434-7. PubMed ID: 1633839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
    Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
    Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
    Scheen AJ; Letiexhe MR; Lefèbvre PJ
    Diabetes Metab; 1999 Jun; 25(2):157-62. PubMed ID: 10443327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.